Prospectively shared control data across concurrent randomised clinical trials

Gopal Kotecha; Steffen Ventz; Lorenzo Trippa

doi:10.1016/j.ejca.2022.11.038

Prospectively shared control data across concurrent randomised clinical trials

Gopal Kotecha, Steffen Ventz, Lorenzo Trippa

Biostatistics

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Sharing data from control groups across concurrent randomised clinical trials with identical enrolment criteria and the same control therapy can translate into efficiencies for the drug development process. We discuss potential benefits and risks of prospective data-sharing plans for concurrent randomised trials.

Original language	English (US)
Pages (from-to)	18-20
Number of pages	3
Journal	European Journal of Cancer
Volume	181
DOIs	https://doi.org/10.1016/j.ejca.2022.11.038
State	Published - Mar 2023

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Ltd

Keywords

Data sharing
Trial design

PubMed: MeSH publication types

Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural

Access

10.1016/j.ejca.2022.11.038

OpenUrl availability

Full text

Cite this

@article{15a8a1109ba843648b43577816653ff3,

title = "Prospectively shared control data across concurrent randomised clinical trials",

abstract = "Sharing data from control groups across concurrent randomised clinical trials with identical enrolment criteria and the same control therapy can translate into efficiencies for the drug development process. We discuss potential benefits and risks of prospective data-sharing plans for concurrent randomised trials.",

keywords = "Data sharing, Trial design",

author = "Gopal Kotecha and Steffen Ventz and Lorenzo Trippa",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2023",

month = mar,

doi = "10.1016/j.ejca.2022.11.038",

language = "English (US)",

volume = "181",

pages = "18--20",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Prospectively shared control data across concurrent randomised clinical trials

AU - Kotecha, Gopal

AU - Ventz, Steffen

AU - Trippa, Lorenzo

PY - 2023/3

Y1 - 2023/3

N2 - Sharing data from control groups across concurrent randomised clinical trials with identical enrolment criteria and the same control therapy can translate into efficiencies for the drug development process. We discuss potential benefits and risks of prospective data-sharing plans for concurrent randomised trials.

AB - Sharing data from control groups across concurrent randomised clinical trials with identical enrolment criteria and the same control therapy can translate into efficiencies for the drug development process. We discuss potential benefits and risks of prospective data-sharing plans for concurrent randomised trials.

KW - Data sharing

KW - Trial design

UR - http://www.scopus.com/inward/record.url?scp=85145821810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85145821810&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2022.11.038

DO - 10.1016/j.ejca.2022.11.038

M3 - Article

C2 - 36621117

AN - SCOPUS:85145821810

SN - 0959-8049

VL - 181

SP - 18

EP - 20

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Prospectively shared control data across concurrent randomised clinical trials

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this